medscopeglobal.com · Léky · EMA
Léková novinka
Přípravek: Retsevmo
Schváleno3. července 2026
Human medicines European public assessment report (EPAR): Retsevmo, selpercatinib, Date of authorisation: 11/02/2021, Revision: 21, Status: Authorised
medscopeglobal.com · Léky · EMA
Přípravek: Retsevmo
Human medicines European public assessment report (EPAR): Retsevmo, selpercatinib, Date of authorisation: 11/02/2021, Revision: 21, Status: Authorised